The catchy language found on coupons for brand-name prescription drugs will likely not produce savings in the end, according to an article in the New England Journal of Medicine. Coupons' savings rarely last more than a year, and insurers pass along costs as higher premiums, according to researchers Dr. Joseph S. Ross and Dr. Aaron S. Kesselheim. PhRMA Senior Vice President Matthew Bennett said coupons may increase the chances that patients get needed drugs. "Today's high levels of cost sharing can pose a significant access barrier for patients, resulting in low adherence and poor health outcomes," Bennett said.

Related Summaries